Financial report interval: 2025.12.31 - 2026.03.31
Preview: Bloomage Biotech(688363) predict that the Revenue is 829.41 M (-23.06%), Miss estimate;the EBIT is 70.9 M (-47.02%), Miss estimate;the EPS is 0.14 (-33.33%), Miss estimate.